Isomorphic Labs, an Alphabet-backed AI biotech firm, raised $600M to boost its AI drug design engine, expand clinical ...
AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict ...
Isomorphic Labs raised $600 million in its first external funding round, led by Thrive Capital with participation from GV and ...
Isomorphic Labs is raising money in its first-ever external funding round from Thrive Capital, a big backer of ChatGPT developer OpenAI ...
The London-based business – which launched in 2021 – will use the funds to further its research, expand its team and continue ...
AI drug discovery firm Isomorphic Labs has completed the company’s first external funding round since its 2021 founding ...
Dallas officials hosted a community briefing and unveiled renderings for the new Kay Bailey Hutchison Convention Center.
Lynx Investment Advisory increased its stake in Alphabet Inc. (NASDAQ:GOOGL – Free Report) by 1.3% in the 4th quarter, ...
Isomorphic Labs, the AI drug-discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600 ...
Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results